Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 24:12:81-84.
doi: 10.1016/j.jdcr.2021.04.006. eCollection 2021 Jun.

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series

Nadine Shabeeb  1 , Molly Hinshaw  1 , Susan Pei  2 , Lauren Craddock  3 , Thomas Keenan  1 , Justin Endo  1
Affiliations
Case Reports

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series

Nadine Shabeeb et al. JAAD Case Rep. .
No abstract available

Keywords: ANA, antinuclear antibody; ATIL, anti-TNF-α-induced lupus; CCLE, chronic cutaneous lupus erythematosus; DILE, drug-induced lupus erythematosus; SCLE, subacute cutaneous lupus erythematosus; SLE, systemic lupus erythematous; TNF inhibitor; TNF, tumor necrosis factor; anti-TNF-α-induced lupus; chilblain lupus; drug-induced lupus erythematosus; pernio; tumor necrosis factor α.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Fig 1
Fig 1
Chilblain lupus associated with TNF-α inhibitor therapy: Clinical images from cases 1 (1A, 1B) and 2 (1C) A and B, Light pink papules on the dorsal and lateral aspects of multiple fingers. C, Violaceous papules on the dorsal and lateral edges of the right first and second fingers.
Fig 2
Fig 2
Chilblain lupus associated with TNF-α inhibitor therapy: Punch biopsy specimen from Case 1 (A, B, C). Hematoxylin-eosin stains; original magnification: ×4 (A) and ×10 (B and C), demonstrating a superficial and deep perivascular and periadnexal lymphocytic infiltrate on acral skin, consistent with chilblain lupus.
Fig 3
Fig 3
Chilblain lupus associated with TNF-α inhibitor therapy: Punch biopsy specimens from cases 2 (A) and 3 (B, C). A, Alcian-blue stain, original magnification: ×10, highlighting mucin in the interstitial dermis. Hematoxylin-eosin stains, original magnification: B, ×4 and C, ×10 demonstrating a dermal perivascular and periadnexal lymphocytic infiltrate, with focal interface changes and rare necrotic keratinocytes.
See this image and copyright information in PMC

References

    1. Hedrich C.M., Fiebig B., Hauck F.H. Chilblain lupus erythematosus–a review of literature. Clin Rheumatol. 2008;27(8):949–954. - PubMed
    1. Dalle Vedove C., Simon J.C., Girolomoni G. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents. J Dtsch Dermatol Ges. 2012;10(12):889–897. - PMC - PubMed
    1. Sifuentes Giraldo W.A., Ahijón Lana M., García Villanueva M.J., González García C., Vázquez Diaz M. Chilblain lupus induced by TNF-α antagonists: a case report and literature review. Clin Rheumatol. 2012;31(3):563–568. - PubMed
    1. Boada A., Bielsa I., Fernández-Figueras M.T., Ferrándiz C. Perniosis: clinical and histopathological analysis. Am J Dermatopathol. 2010;32(1):19–23. - PubMed
    1. Cribier B., Djeridi N., Peltre B., Grosshans E. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol. 2001;45(6):924–929. - PubMed

Publication types

LinkOut - more resources